PFBT
LENZ

Parkside Financial Bank & Trust’s LENZ Therapeutics LENZ Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$504 Buy
+55
New +$773 ﹤0.01% 2568

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Parkside Financial Bank & Trust's LENZ Position: Q1 2026 in Review

Parkside Financial Bank & Trust opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 55 shares worth $504. The stake represents ﹤0.01% of the portfolio and ranks #2568 among its holdings.

145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Parkside Financial Bank & Trust held 55 shares of LENZ Therapeutics worth $504 as of Q1 2026.
  • LENZ Therapeutics was a new Parkside Financial Bank & Trust position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2568 holding.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.